Granulocytes generate a ''respiratory burst'' of NADPH oxidasedependent superoxide anion (O 2 ؊• ) production that is required for efficient clearance of bacterial pathogens. Hv1 mediates a voltagegated H ؉ channel activity that is proposed to serve a chargebalancing role in granulocytic phagocytes such as neutrophils and eosinophils. Using mice in which the gene encoding Hv1 is replaced by ␤-Geo reporter protein sequence, we show that Hv1 expression is required for measurable voltage-gated H ؉ current in unstimulated phagocytes. O 2 ؊• production is substantially reduced in the absence of Hv1, suggesting that Hv1 contributes a majority of the charge compensation required for optimal NADPH oxidase activity. Despite significant reduction in superoxide production, Hv1 ؊/؊ mice are able to clear several types of bacterial infections.
HV1 Ϫ/Ϫ ͉ immunity ͉ voltage-gated ion channel ͉ innate immunity T he voltage-gated H ϩ channel Hv1 (also termed VSOP or BTS) was identified by its homology to the voltage sensor domain of voltage-gated cation channels and a voltage-regulated phosphatase Ci-VSP (1) (2) (3) (4) . Hv1 is encoded by the Hvcn1 gene, and both protein function and genetic sequences are well conserved from primitive chordates to mammals (1, 2) . Expression of Hv1 in either mammalian cells or Xenopus oocytes is sufficient to reconstitute the hallmark biophysical properties of native voltage-dependent H ϩ conductances (G vH ϩ): activation by transmembrane depolarization or net intracellular acidification, exquisite H ϩ -selective conductance, and sensitivity to inhibition by micromolar Zn 2ϩ (1, 2, (5) (6) (7) (8) . Under resting physiological conditions in most cells (pH i Ϸ pH o ), the channel's voltagedependent gating dictates that protons flow only outward through Hv1, suggesting that a prominent physiological role for the channel is to secrete H ϩ (5).
Voltage-gated H ϩ currents and Hv1 protein are prominently expressed in granulocytic phagocytes such as neutrophils and eosinophils (1, 3, 5, 9) ; granulocytes are characterized by their ability to mount a ''respiratory burst'' of high-level NADPH oxidase-dependent superoxide anion (O 2 Ϫ• ) production that is required for clearance of bacterial pathogens (10) . NADPH oxidase would cause a rapid intracellular acidification and profound depolarization of the cell membrane in the absence of a balancing charge movement, and G vHϩ mediated by Hv1 is ideally suited to meet this physiological requirement (11) (12) (13) (14) . To investigate whether Hv1 is required for innate immune function, we generated an Hv1 knockout mouse (Hv1 Ϫ/Ϫ ) line and assessed voltage-gated H ϩ current, O 2 Ϫ• production, and bacterial clearance in Hv1 Ϫ/Ϫ mice and their wt/wt littermates. Our results demonstrate that Hv1 is required for G vHϩ , a robust respiratory burst, and efficient bacterial clearance in vitro.
Results
The Bay Genomics genetrap of the Hvcn1 locus leads to transcription of a transgenic mRNA that contains a ␤-Geo reporter gene sequence in place of the Hv1 protein coding sequence, such that only the 6 N-terminal residues of Hv1 are translated (Fig.   S1 ). RRN293 ES cells bearing the Hvcn1 genetrap allele were used to generate a transgenic mouse line that that is expected to lack Hv1 protein expression and voltage-gated proton channel activity. Triplex genomic PCR demonstrated the expected Hvcn1 size difference for the wt and transgenic alleles (Fig. 1A) , and was used in conjunction with quantitative genomic PCR for genotypic screening during breeding. Homozygous RRN293 mice lack detectable levels of Hv1 protein in spleen, bone marrow cells (BMC), and peripheral blood leukocytes (Fig. 1B) , indicating that the genetrap strategy results in an effective Hv1 knockout (Hv1 Ϫ/Ϫ ). Consistent with the reported expression of G vHϩ in alveolar epithelial cells (15, 16) , we detected Hv1 protein in lung homogenates from wt/wt but not Hv1 Ϫ/Ϫ mice (Fig. S1 ).
Hv1 protein was not detectable in hippocampal microsomes, suggesting that the lack of detectable voltage-gated H ϩ current in mammalian neurons results from low Hv1 expression (17) . Consistent with previous reports (18, 19) we measured G vHϩ in acutely isolated non-neuronal hippocampal cells (presumably microglia) but not in Hv1 Ϫ/Ϫ cells. The relative paucity of microglia could account for undetectably low levels of Hv1 protein in brain, and future studies should investigate Hv1 expression and function in microglia in situ. We next measured voltage-gated whole-cell H ϩ currents in leukocytes isolated from wt/wt or Hv1 Ϫ/Ϫ mice as described (1) . Purified resting (round and nonadherent) granulocytes exhibited G vHϩ at varying levels, but Hv1 Ϫ/Ϫ mice lacked detectable H ϩ current ( Fig. 2 B and D) . Consistently larger currents were measured in cells displaying the morphological characteristics (presence of pseudopodia and a uropod, spontaneous adherence and cytokinesis on glass substrate) of circulating neutrophils (Fig. 2 A) . The apparent threshold for voltage-dependent activation (V thr ) of H ϩ currents elicited by depolarizing voltage steps was approximately ϩ40 mV under symmetrical recording conditions ( Fig. 2C ; pH i ϭ pH o ϭ 6.5). As expected for authentic G vHϩ , V thr shifted negatively Ϸ40 mV when a 1-log unit outward [H ϩ ] gradient (pH i ϭ 6.5, pH o ϭ 7.5) was imposed ( Fig. 2C) (5, 7) . In no instance were we able to measure detectable voltage-activated H ϩ currents in cells isolated from Hv1 Ϫ/Ϫ mice ( Fig. 2 B and D) , indicating that Hv1 expression is required for G vHϩ . In combination with previous results demonstrating that Hv1 is sufficient to reconstitute G vHϩ (1, 2) , these results suggest that Hv1 intrinsically forms the voltage-dependent proton channel that underlies G vHϩ in various cell types. The existence of additional genes encoding voltagegated proton channels therefore seems unlikely. This conclusion is further supported by the observation that native G vHϩ and expressed Hv1 share unique biophysical properties (especially the invariant coupling of V thr to the pH gradient) that are conserved in a wide variety of cell types (5, 7). Cell-specific factors are likely to modulate Hv1 channel properties, particularly in cells such as neutrophils, where G vHϩ appears to be posttranslationally regulated by signaling cascades (20) (21) (22) .
Two lines of evidence suggested that G vHϩ might be necessary for sustained O 2 Ϫ• production during the respiratory burst: first, outward H ϩ current through Hv1 should balance the outward e Ϫ current produced by the active NADPH oxidase, thereby limiting membrane depolarization that would otherwise inhibit NADPH oxidase activity (11) (12) (13) (14) ; second, Hv1 allows for extrusion of intracellular protons that are produced by NADPH oxidase, thus limiting intracellular acidosis and maintaining optimal O 2 Ϫ• production (23) (24) (25) . To test the hypothesis that Hv1 is required for high-level superoxide production, we isolated BMC from wt and Hv1 Ϫ/Ϫ mice and measured phorbol 12-myristate 13-acetate (PMA)-stimulated O 2 Ϫ• and hydrogen peroxide (H 2 O 2 ) production spectrophotometrically (Fig. 3 and Fig. S2 ). PMA (200 nM) elicited a robust time-dependent increase in O 2 Ϫ• production that was absent in vehicle-treated control cells and largely blocked by dephenylene iodonium (DPI; 10 M), an inhibitor of NADPH oxidases (Fig. 3A) . After an initial delay, the rate of O 2 Ϫ• production (measured 1-3 min after PMA addition at 37°C) was attenuated Ϸ65% in cells from Hv1 Ϫ/Ϫ mice compared with wt/wt littermates (Fig. 3B) , and a similar decrement was observed 15 min after PMA addition (Fig. 3A) . DPI (10 M) inhibited 79% and 73% of the PMA-stimulated O 2 Ϫ• production (at 15 min) in wt/wt and Hv1 Ϫ/Ϫ BMC, respectively (Fig. 3A) . Similar results were observed in peripheral blood leukocytes (PBL) purified from either Lympholyte M or discontinuous Percoll gradients, and BMC isolated from Hv1 Ϫ/Ϫ mice with mixed C57BL/6J host and 129 ES cell genetic background were not significantly different from back-crossed Hv1 Ϫ/Ϫ B5 mice. Finally, PMA-stimulated H 2 O 2 production was also substantially decreased in Hv1 Ϫ/Ϫ BMC compared with wt/wt controls (Fig. S2) .
In contrast to intact cells, O 2 Ϫ• production was not different in a broken-cell preparation made from either wt/wt or Hv1 Ϫ/Ϫ BMC (Fig. 3C) . Consistent with the idea that Hv1 is required for charge compensation and H ϩ efflux in intact cells but is irrelevant in membrane fragments that do not experience changes in voltage or pH gradients after NADPH oxidase activation. In addition, we observed similar levels of p22 phox expression in wt/wt and Hv1 Ϫ/Ϫ BMC microsomes (Fig. 3D) . Together, these results suggest that attenuated O 2 Ϫ• production in Hv1 Ϫ/Ϫ cells is unlikely to result from a decrease in the activity or expression of NADPH oxidase complex components per se. Although our data do not rule out the possibility that other gene products or ion transport pathways also contribute to charge compensation during the phagocyte respiratory burst, they suggest that Hv1 is likely to play a central role in electrical and H ϩ gradient homeostasis that is required for optimal NADPH oxidase activity under physiological conditions in mouse granulocytes (12, (25) (26) (27) (28) (29) (30) (31) (32) .
The role of the respiratory burst in innate immune function is illustrated by the observation that deletion or mutation in any of several protein components comprising the NADPH oxidase complex impairs bacterial clearance in mice and causes chronic granulomatous disease in humans (10) . To determine whether the attenuated O 2 Ϫ• production that we observed in Hv1 Ϫ/Ϫ cells would adversely affect bacterial clearance, we incubated wt or Hv1 Ϫ/Ϫ BMC with live, serum-opsonized Staphylococcus aureus and assayed bacterial survival. BMC from both wt/wt and Hv1 Ϫ/Ϫ mice cleared Ͼ90% of the added bacteria (Fig. 4A) , suggesting that the viability and bacterial killing function of BMC isolated from both wt/wt and Hv1 Ϫ/Ϫ mice is similar. NADPH oxidasedependent bacterial killing was significantly attenuated in Hv1 Ϫ/Ϫ compared with wt/wt mice (Fig. 4 A and B) . Bacterial survival was similar in the presence of DPI, suggesting that NADPH oxidase-independent mechanisms of bacterial clearance were unchanged in Hv1 Ϫ/Ϫ cells and that Hv1 deletion selectively affects NADPH oxidase-dependent killing. Furthermore, phagocytosis of heat-inactivated, fluorescently-labeled, serum-opsonized S. aureus or E. coli was not different in Hv1 Ϫ/Ϫ and wt/wt cells, suggesting that the observed defect in bacterial clearance is caused by reduced O 2 Ϫ• production and not by a change in the abilty of Hv1 Ϫ/Ϫ cells to phagocytose bacteria.
We next tested whether Hv1 Ϫ/Ϫ mice are able to clear bacterial infections in vivo. Hv1 Ϫ/Ϫ or wt/wt mice were inoculated i.p. with S. aureus, and surviving bacteria were elaborated on selective agar from peritoneal lavage fluid h 6-24 later. In mice inoculated with 1 ϫ 10 8 S. aureus we observed a Ͼ2-log unit decrease in bacterial CFU after a 24-h incubation in vivo (Fig. 4C) . Whereas mice that received 1 ϫ 10 8 CFU of S. aureus did not visibly manifest sepsis, mice of either genotype that received 5 ϫ 10 9 CFU were typically moribund within 6 h of inoculation. Although bacterial load in the peritoneal lavage from Hv1 Ϫ/Ϫ mice suggested a trend toward decreased bacterial clearance, the data did not reach statistical significance. We also observed robust clearance of experimental pneumonia 24 h after intranasal inoculation of 1 ϫ 10 8 CFU Pseudomonas aeurginosa or Burkholderia cepacia in both wt/wt and Hv1 Ϫ/Ϫ mice. Although Hv1 deletion reduces Hv1 protein and G vHϩ to undetectably low levels, decreases O 2 Ϫ• production by Ϸ75%, and significantly attenuates bacterial killing in vitro, we were unable to see a significant effect on bacterial clearance in vivo under our experimental conditions.
Discussion
In summary, we demonstrate here that Hv1 is necessary for measurable G vHϩ in a variety of leukocytes, and previous studies showed that expression of Hv1 is sufficient to reconstitute the hallmark biophysical properties of G vHϩ in heterologous systems (1, 2, (5) (6) (7) (8) . Superoxide production by intact (but not broken) cells is substantially reduced in the absence of Hv1. The simplest interpretation of these results is that Hv1 serves to provide a majority of the charge compensation needed to support NADPH oxidase-mediated e Ϫ export. Despite a significant reduction in superoxide production, wt/wt and Hv1 Ϫ/Ϫ mice were similarly able to clear S. aureus infections in vivo, but differences in innate immune function may become apparent under different experimental conditions. Similar to human patients with chronic granulomatous disease, mice bearing targeted deletions or mutations of genes encoding NADPH oxidase components manifest symptoms (e.g., dramatically decreased or undetectable O 2 Ϫ• production and decreased bacterial clearance in vitro and in vivo) (33) (34) (35) (36) . Interestingly, mice lacking either gp91 phox (the product of the Nox2 gene) or inducible nitric oxide synthase (the Nos2 gene product) exhibited a similarly modest impairment in the innate immune response to S. aureus challenge. In vivo, Nox2
Ϫ/Ϫ / Nos2 Ϫ/Ϫ (double-knockout) mice required administration of oral antibiotics for survival even in the absence of bacterial challenge, suggesting that normal innate immune function relies on at least partially redundant systems for bacterial clearance (37) . Thus, superoxide-and nitric oxide-dependent systems appear to function synergistically for bacterial clearance in vivo. Reconstitution of a small fraction of the total superoxidegenerating capacity of the innate immune system in gp91 phox (Nox2 Ϫ/Ϫ ) knockout mice was sufficient to significantly restore bacterial clearance, suggesting the presence of enormous excess capacity for NADPH oxidase-dependent superoxide production in normal granulocytes (38) (39) (40) . Because O 2 Ϫ• generation was decreased Ϸ75% in Hv1 Ϫ/Ϫ mice, the lack of a significant in vivo impairment in bacterial clearance in these mice is perhaps not surprising. Hv1 Ϫ/Ϫ mice should be useful for investigating the physiological role of Hv1 in cells and tissues outside of the innate immune system in the future.
Materials and Methods
Hv1 Knockout Mice. Mice lacking functional Hv1 protein were derived from the Bay Genomics genetrap of the Hvcn1 locus (dbGSS7585445; gi37500117). The exogenous genetrap vector sequence, containing an in-frame splice acceptor site followed by coding sequence for a ␤-galactosidase/neomycin (␤-Geo) fusion protein, was inserted into a large (13.6 kb) intron following exon 2, which contains the Hv1 translation initiation codon. Chimeric male mice were derived from sequence-verified RRN293 genetrap ES cells and used to establish heterozygous wt/RRN293 founders; homozygous offspring were generated from heterozygous mating pairs (Mutant Mouse Regional Resource Center, Davis, CA). Hv1 Ϫ/Ϫ mice backcrossed against C57/BL6J for 5 generations are designated B5. All animal husbandry and experimental procedures were approved by and performed in accordance with guidelines of the Children's Hospital Boston Institutional Animal Care and Use Committee.
Mouse Genotyping. The genomic locus of the Bay Genomics genetrap vector (pGTOLxf ) insertion was identified by PCR using a series of forward primers spaced at 1-to 2-kb intervals in the predicted intronic Hvcn1 sequence, along with a ␤-Geo-specific reverse primer (␤-GeoR: 5Ј-GACAGTATCGGC-CTCAGGAAGATCG-3Ј) to amplify a product containing the pGTOLxf insertion site. DNA sequencing of the PCR product (Mental Retardation/ Developmental Disabilities Research Center Molecular Genetics Core Facility at Children's Hospital) indicated that the pGTOLxf vector was inserted after nucleotide 13899 (of 17054) in predicted intron 3 (variant 1, Fig. S1A ). Genotypes were confirmed by triplex PCR performed on genomic DNA isolated from mouse tails using 2 gene-specific primers (Hvcn1F: 5Ј-GAGATCCATCTGCCTCCGTTATGAGTG-3Ј; Hvcn1R: 5Ј-CATGGTCTCAGT-GATGTTAGGACGTC-3Ј) and ␤-GeoR. The genotypes of mice used for breeding were determined by quantitative genomic PCR (Transnetyx) using primers specific to Hvcn1 intron 3 and pGT0Lxf; results from the Transnetyx genotyping strategy were verified by triplex genomic PCR. Although quantitative RT-PCR confirmed that the RRN293 transgene was expressed at the expense of the wt Hvcn1 allele (Fig. S1C ), we were unable to detect either ␤-galactosidase protein [using several different anti-␤-galactosidase antibodies in Western blot analysis, immunocytochemistry (ICC) or immunohistochemistry (IHC)] or activity (using X-gal staining) in spleen or BMC from Hv1 Ϫ/Ϫ mice.
Quantitative RT-PCR. Total RNA (500 ng) extracted from mouse BMC (Rneasy; Qiagen) was reverse-transcribed by using an oligo(dT) primer (SuperScript 3; Invitrogen). Quantitative PCR (Real time PCR systems 7300; Applied Biosystems) was performed in a final volume of 25 L containing 40 ng of cDNA, 300 M primers (Hvcn1 Ex1 Fwd: 5Ј-TGCAAAGGAGTGCTGCAAACTA-3Ј; Hvcn1 Ex1 Rev: 5Ј-TCGAGTAGACGCTCCGCAAT-3Ј; Hvcn1 Ex2-3 Fwd: 5Ј-CTCTCACTGTT-GGATCTTGAGACAA-3Ј, Hvcn1 Ex2-3 Rev: 5Ј-GGGAGCCACCTTGGTTCTG-3Ј; ␤-Geo Fwd: 5Ј-GGACGCGCGAATTGAATTA-3Ј, ␤-Geo Rev: 5Ј-CTGTTGACTG-TAGCGGCTGATG-3Ј), and 12.5 L of SybrGr PCR master mix (Applied Biosystems). Triplicate quantitative PCRs were performed by using BMC cDNA synthesized from wt/wt or RRN293/RRN293 mRNA isolated from 3 mice of each genotype. Normalized values for cycle threshold (⌬Ctwt/wt and ⌬CtRRN/RRN) were calculated by subtracting the observed cycle threshold (Ct) for each cDNA and primer pair from the Ct observed for L8 ribosomal RNA primers (2) . Relative expression of ␤-Geo (Fig. S1 , primers H and I) or Hvcn1. Relative expression of ␤-Geo mRNA (Fig. S1 , primers H and I) in wt/wt BMC and Hvcn1 mRNA in RRN293/RRN293 BMC [ Fig. S1 , primers D and E (Hvcn1 Ex 1Ј, 1Љ) or primers F and G (Hvcn1 Ex 2-3)] was calculated by using Eqs. 1 and 2. Eq. 1. Fractional ␤-Geo expression in wt/wt ϭ 2 Ϫ⌬⌬Ct␤-Geo , where ⌬⌬Ct␤-Geo ϭ ⌬Ctwt/wt Ϫ ⌬CtRRN/RRN (primers H and I) and ⌬Ctwt/wt ϭ CtHvcn1Ex1 Ϫ CtL8RNA and ⌬Ctwt/wt ϭ Ct ␤-GeoRNA Ϫ Ct L8RNA . Eq. 2. Fractional Hvcn1 expression in RRN293/RRN293 ϭ 2 Ϫ⌬⌬CtHvcn1 , where ⌬⌬Ct ϭ ⌬CtRRN/RRN Ϫ ⌬Ctwt/wt (primers D, E and F, G). Immunoblotting. Membranes were prepared from cell pellets or tissues by homogenization (1-2 min; Polytron) in ice-cold homogenization solution, 150 mM NaCl, 10 mM Tris⅐HCl (pH 7.2), 1 mM EDTA containing 0.3 M sucrose and protease inhibitor mixture (Complete mini; Roche; mammalian cell protease inhibitor mixture; Sigma) and sonicated (3 ϫ 5 s, 40% maximum power, Heat Systems-Ultrasonics W225) before centrifugation (10 min, 4,000 ϫ g, 4°C) to clear nuclei and particulate material. The supernatant was then centrifuged (30 min, 25,000 ϫ g, 4°C; Sorvall Ultrafuge) to pellet cell membranes. Membranes were solubilized by sonication (3 ϫ 5 s, 25% maximum power) in 0.2 mL of ice-cold lysis buffer (TSϩEGTA containing 1% Triton X-100 and protease inhibitors). Protein concentration was determined (Bradford, BioRad protein assay) and 30 g per lane was loaded onto 4 -12% Bis-Tris Novex Nu-PAGE gels (Invitrogen) for electrophoresis in Mops running buffer before transfer to a PVDF membrane. Western blots were incubated with rocking in PBST (D-PBS containing 0.5% Tween-20) blocking solution containing 5% nonfat dry milk (60 min, 24°C). Blots were first incubated with an anti-actin (Chemicon) primary antibody (1:1,000, 2 h, 24°C) followed by secondary antibody (goat anti-mouse HRPconjugated IgG; Zymed; 1:100,000, 45 min, 24°C). Immunoreactivity was detected by using ECL Advance (Amersham). Blots were stripped (20 min, 50°C) in 67.5 mM Tris⅐HCl (pH 6.8), 100 mM ␤-mercaptoethanol, and 2% SDS and washed with PBST before sequential incubation with anti-Hv1 primary (4234, 2 h) (1) and secondary (goat anti-rabbit HRP-conjugated IgG; Zymed; 1:100,000, 45 min) antibodies. Phase-dark cells were counted (after 5 min at 24°C) with a glass hemacytometer and diluted to 5 ϫ 10 6 /mL in ice-cold TS. Cells (0.1ϫ final volume) were added to individual cuvettes containing TS plus 100 M cytochrome c (or 5 M Amplex Ultra Red and 0.5 unit/mL horseradish peroxidase for H 2O2 production assay) with or without DPI (10 M) or ZnCl2 (1 mM). O 2 Ϫ• and H2O2 production were measured at 550 nm, 37°C, in 1.0 mL of cuvettes by using a temperature-controlled spectrophotometer fitted with an automated 6-cuvette sample changer (DU800; Beckman-Coulter). Medium containing assay reagent and indicated drugs was preincubated (37°C) for 10 min; cells were added 5 min before addition of PMA (200 nM) or arachidonic acid (AA, 100 M) and absorbance was measured in a final volume of 1.0 mL (cuvette assay). O 2 Ϫ• and H2O2 production in wt/wt and Hv1 Ϫ/Ϫ BMC were measured in parallel assays conducted simultaneously using the automated sample changer.
Isolation of Mouse

H2O2 Production Assay (96-Well Format)
. BMC or HL-60 cells were centrifuged (250 ϫ g, 10 min) and resuspended in TS on ice. Cells were counted and diluted to 5 ϫ 10 6 /mL in ice-cold TS. Cells (20 L) were added to individual wells containing ice-cold TS plus indicated assay reagent with or without PMA (200 nM), DPI (10 M), or ZnCl2 (1 mM). Assay plates containing added assay reagents and indicated drugs (minus PMA) were preincubated in a warm-air incubator (37°C) for 10 min Cells were added and incubated (37°C) for an additional 5 min. Plates were removed and t ϭ 0 assigned as immediately after PMA addition. H 2O2 secretion was measured at room temperature by using a plate-reading spectrophotometer/fluorimeter (550 Ϯ 8-nm filter, Victor3; Wallac) in a final volume of 0.2 mL per well. All assay wells contained 5 M Amplex Ultra Red (Invitrogen) and 0.5 unit/mL horseradish peroxidase (Zymed). In control experiments where PMAstimulated O 2 Ϫ (cytochrome c reduction) and H2O2 (Amplex Ultra red) were measured side by side in a heated cuvette-reading spectrophotometer (1.0-mL assay volume), we observed only a small delay in H 2O2 generation compared with O 2 Ϫ production, suggesting that the slow time course observed in some experiments (Fig. S2 ) was attributable to slow heating and reheating of the reagents and plates in the 37°C warm air incubator between time points that were measured using the nonheated spectrophotometric plate reader.
In Vitro Bacterial Killing. Aliquots of bacterial stocks (stored at Ϫ80°C in 20% glycerol) on dry ice were scraped with a sterile needle and bacteria were spread on selective agar plates (S. aureus: mannitol, Molecular Toxicology; P. aeurginosa: cetrimide, PML Microbiologicals; B. cepacia: BCSA, PML Microbiologicals) and grown overnight at 37°C. LB medium was subsequently inoculated and liquid cultures were grown with shaking at 37°C to an OD600 Ϸ 0.5. The concentration of bacterial CFU was calculated (OD600 ϭ 0.5, CFU ϭ 5 ϫ 10 5 /L) and verified for each bacterial preparation by serial dilution and plating onto selective agar plates. Bacteria were centrifuged (10 min, 1,000 ϫ g, 4°C) and resuspended and opsonized in mouse serum containing 0.05% Tween-20 (30 min with rotation, 24°C). Opsonized bacteria were then diluted into TS containing 0.05% Tween-20 to 2 ϫ 10 4 CFU/L. BMC were resuspended in ice-cold TS (10 6 cells per 100 L) and added to round-bottom tubes containing TS solution with or without DPI (10 M). The assay was initiated by addition of bacteria (50 L) and allowed to proceed for 30 min (37°C, orbital shaking) before addition of gentamicin (50 g/mL; Sigma) and centrifugation (10 min, 2,800 ϫ g, 24°C). Cell pellets were washed in TS ϩ EGTA and lysed by resuspension in saponin (1% in water) and 1 freeze-thaw cycle. Lysates were serially diluted and plated onto selective LB agar for overnight culture (37°C) for manual determination of bacterial CFU. Although DPI reproducibly inhibited killing of bacteria under these experimental conditions, a large fraction of the inoculum survived even in the presence of DPI (Fig. 4 A) , suggesting that mouse BMC may use NADPH oxidase-independent mechanisms for bacterial killing that are not prominent in purified, circulating human neutrophils and/or that incomplete cell lysis may have led to an underestimate of the DPI-dependent fraction of bacterial killing (42) . Our results should therefore be interpreted as a lower limit on the effect of Hv1 deletion on bacterial killing by the NADPH oxidase system.
In Vivo Bacterial Clearance. Bacteria were grown to OD 600nm Ϸ0.5, centrifuged (10 min, 1,000 ϫ g, 4°C), and resuspended in sterile 0.9% NaCl or D-PBS to a final concentration of 2 ϫ 10 8 CFU/mL (i.p.) or 2 ϫ 10 10 CFU/ml (intranasal) for inoculation. Mice were allowed to recover for 18 -24 h after i.p. or intranasal inoculation before peritoneal (3 ϫ 5 mL of D-PBS, 4°C) or lung lavage (3 ϫ 0.8 mL of D-PBS, 4°C), respectively. Lavage fluid was centrifuged (10, 1,000 ϫ g, 4°C) and the pellet was resuspended in D-PBS containing 0.05% Tween-20 (PBST), then serially diluted in PBST before plating on selective agar plates for culture at 37°C for 24 -48 h. 
